From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...

Discover how biosimilars in Europe expand access, cut costs, and strengthen healthcare systems for a more sustainable future.

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.

October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

From growing mini-organs to reviving the dodo and gene-editing embryos, boundaries between sci-fi and today's advances are ...

Discover how AI and agentic workflows help chemists accelerate drug design, generate hypotheses, and analyze data in real ...